HHAT and breast carcinoma: Hhat knockdown or treatment with RU-SKI 43 was shown to inhibit oestrogen receptor positive, HER2 amplified and tamoxifen-resistant breast cancer cell growth, while Hhat overexpression increased ER positive cell proliferation [66].